The World’s Most Expensive Drug

Priced at a staggering $2.125 million per patient,  Zolgensma is now the world’s most ...

The Why and How of Hub Services

When it comes to conducting benefits investigations, initiating prior authorizations, and accomplishing other patient ...

Changes to Medicare Part D Continue to Evolve

With the Bipartisan Budget Act of 2018 (BBA), Congress made changes to the Medicare ...

Endangered PBMs’ Best Option for the Future

Pharmacy benefit managers (PBMs) have been under fire for some time now. Many of ...

Is the Digital Health Formulary a Rising Tide?

One of the earliest formularies on record is the 1816 Pharmacopoeia of the New York ...

How Safe are Safe Harbor Regulations?

The phrase “no more rebates” and recent guidance from the Department of Health and ...

Drug Pricing Regulatory Action Near Certain

It is never a good sign when reputational polls show that your industry ranks ...

Hub Services Offer Big Benefits for Retail Launch Brands

Along with their specialty brand counterparts, retail brands are starting to experience the pain ...

Dealing with Insurers’ Copay Accumulators

Over the past couple of years, more and more insurers have started to implement ...

The Scrutiny on Rebates and Prices Will Change the Pharma-Payer Relationship

The government is the largest payer in the U.S. through Medicare and Medicaid, and ...

Four Key Questions About Payer Strategies in 2019

PM360 asked those with expertise in payer strategies how changes are impacting pharma’s relationship ...